Catalyst Wire Dossier Catalyst Wire Dossier

Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

· Sinovac Life Sciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells), covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) [Phase 2]

See pricing